Pharmacokinetics, Pharmacodynamics, and Safety of NANOKINE Compared With Eprex 4000 U in Healthy Volunteers
Clinical trial NCT06919861 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06919861
- Sponsor
- Nanogen Pharmaceutical Biotechnology Joint Stock Company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2026-12-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.